Business services, nec, nec
Merrimack Pharmaceuticals, Inc
Merrimack Pharmaceuticals is a privately held integrated biotechnology company. The company is dedicated to the discovery and development of therapies for the treatment of autoimmune disease and cancer. Its goal is to provide patients and physicians with some of the best possible treatments and support its pharmaceuticals with the tools to enable the prescription of the right drug for the right patient. The company is advancing a pipeline of clinical and early-stage biologics that represent patient-directed, targeted therapies. Its discovery and development efforts are founded on its proprietary Network Biology research engine. Its lead product, MM-093, is in clinical trials for the treatment of patients with rheumatoid arthritis and psoriasis. Merrimack Pharmaceuticals is based in Cambridge, Mass.